Posts

What’s The Best City in the US for a Medtech Hub?

Here’s What ChatGPT Recommends …

In a recent Executive AI Bootcamp, our group of 25 CEOs discovered how to use Gen AI to enhance their strategic capabilities. We chose a use case of  selecting the best SMSA to locate a research and development center for a respiratory products medtech company, backed by private equity, that sought to become the market leader in its sector. ChatGPT gave us its recommendation, based on a set of criteria we provided.

That’s a timely, real-time use case it turns out, with a little twist.

Under the 2022 CHIPS and Science Act, the US Department of Economic Development, will award ten tech hubs in the US a $40-70 million investment. The goal is to invest in regions that have the potential to be global powerhouses, leveraging their technology, today and in the future, to grow employment and revenue.

The CHIPS and Science Act initiative brings together diverse stakeholders from the public, private, and academic sectors. The desired outcome will create Tech Hubs that build the workforce of the future, enable businesses to start and scale, and deploy and deliver critical and emerging technologies.

Medical technology has been identified as a key focus area. A recent Twin Cities Business article, Minnesota’s Campaign for MedTech Prominence, profiled several local medical device CEOs and others on the topic, who are lobbying for the Greater Minneapolis-St. Paul SMSA to be chosen for a tech hub. So, let’s put it to the test.

I prompted several Gen AI large language models to provide the right answer. Modifying our prompts from the AI for Strategy session at the bootcamp, here’s the prompt fed to ChatGPT4, Claude Opus 3 Haiku and Perplexity for the definitive recommendation.

Spoiler alert. ChatGPT4 chose Minneapolis-St. Paul as the overall winner. But not without some controversy. The other LLMs had different ideas.

Play the role of a skilled panel of judges with deep medtech / healthtech industry experience. The judges are considering the following metropolitan areas for the “smart med” designation. The overall winner will receive investment from the CHIPS and Science Act. The cities are: Boston, Minneapolis-St. Paul, Research Triangle Park, San Diego, Orange County, CA, San Francisco-Bay Area, Seattle and Austin.

Please do a broad-based assessment that includes the following factors:

  1. Supply of labor and skilled medtech human capital.
  2. Local tax situation and business climate.
  3. The health of the medtech/healthtech ecosystem of each SMSA, to include the size and impact of medtech / healthtech companies, the quality of nearby universities, the quality of healthcare providers, healthcare insurers and availability of venture capital firms.
  4. Ease of transportation and infrastructure.
  5. Community support.
  6. Quality of life and affordability.
  7. Other considerations you may identify.

Present a summary for each city. Create a table that evaluates each SMSA on these factors. Provide an overall recommendation of your top 3 finalists. Finally, choose an overall winner.

Here’s how the LLM’s responded:

ChatGPT4

Overall Winner: Minneapolis-St. Paul

Recommended Medtech Hub Finalists: Boston, Minneapolis-St. Paul, Research Triangle Park

Claude 3 Opus Haiku

Overall Winner: Boston

Recommended Medtech Hub Finalists: Boston, Minneapolis-St. Paul, Research Triangle Park

Perplexity

Overall Winner: Boston

Recommended Medtech Hub: Boston, San Diego, Minneapolis-St. Paul

The most widely used LLM, the workhorse of Gen AI, ChatGPT, chose Minneapolis-St. Paul as its recommended winner. The other two LLMs chose Boston. Both Minneapolis-St. Paul and Boston were mentioned in all three, while Research Triangle Park was mentioned twice and San Diego once.

What do you think? If you were the distinguished panel of judges, which city would you pick for investment as the premier medtech hub in the US?

GenAI and Medtech CEOs: What I’ve Learned

To Thrive in An AI-World, Leaders Must Master New Skills to Be More Productive, Creative and Strategic 

It’s been one year today since ChatGPT launched and brought generative AI into the mainstream. In just five days, over one million people tried ChatGPT – it took Twitter two years to hit that milestone. And in 2023, terms like “artificial intelligence,” “generative AI,” and “AI” are ubiquitous in business publications.

ChatGPT and other large language models (LLMs) allow us to write a prompt and see GenAI’s superpowers at work within seconds. It excels at generating and synthetizing text, video, audio, images and code. It’s also exceptional at brainstorming and generating ideas, completing tasks and interacting. However, it’s not perfect. It’s quirky and sometimes provides wrong answers.

Is this GenAI hype or the real deal? The jury is still out, but the quality of the LLMs is improving rapidly.  CEOs are jumping on board – mentions of AI on S&P 500 earnings calls have tripled compared to last year according to Bloomberg. And CEOs are putting their money where their mouths are. The investments and projections are staggering:

  • AI investments could approach $200 billion globally by 2025 (Goldman Sachs).
  • AI could contribute over $15 trillion to the global economy by 2030 (PwC).
  • AI productivity gains could reach $4.4 trillion (McKinsey).

In the medtech and healthtech sectors, moving to the “AI class” is vital.  2023 has been challenging – EY projects anemic 0.4% revenue growth versus the modest 3.5% growth last year. Slow growth and shrinking margins make productivity gains imperative. Meanwhile, AI in healthcare is projected to have an 85% CAGR through 2027 – faster than any other industry – and becoming a $22 billion market (BCG).

While medtech has been slow to adopt AI, firms that embrace it can optimize productivity, accelerate revenue and transform their businesses with new innovative AI-augmented products and services.

Productivity starts at home. An HBS/BCG study showed AI boosts knowledge worker productivity 66% on certain tasks. The productivity gains apply to executives, too. Yet, in my discussions with CEOs and senior leaders, most executives admit they don’t use AI in their daily work. They know “AI” as a term but haven’t realized its potential. That is a risky position. While AI may not take your job, someone who knows and uses AI soon will. When I ask these leaders if they would like to learn how ChatGPT, Claude and other AI-based tools can save them time, make them more creative and improve decisions, I get an overwhelming “Yes!”

Yesterday, I gave a CEO client a ninety-minute abbreviated version of the AI for Executive Productivity workshop. First, we identified the work he does that requires both brain and brawn. His list of “use cases” included:

  • Preparing the board deck and prepping for the board meeting.
  • Preparing for important meetings with key customers and investors. Gaining updated news about their companies, thinking of ideas to build rapport, questions to ask, questions to anticipate.
  • Writing the monthly letter to all employees
  • Preparing, writing and sending emails
  • Analyzing the monthly financial reports
  • Analyzing and summarizing industry financial reports such as proxy statements, annual reports, S-1s and 10Ks.
  • Reading and summarizing analyst and industry specific reports.
  • Preparing for sales calls.
  • Preparing for and rehearsing difficult conversations.
  • Writing performance reviews.

One-by-one, we took each of his use cases and he discovered first-hand how gen AI can help with a first draft or complete each of these tasks as an assistant, a strategist or a creator.  In ninety minutes, we just skimmed the surface, but he was amazed and sees the potential. Hours and hours of drudge work will be saved each month. Imagine if you and your team was AI-fluent and applied it daily. What would that be worth?

The takeaway is clear: AI is here to stay and rapidly improving. Leaders who don’t skill up on AI’s potential will struggle to remain competitive and become obsolete.  Medtech firms that fail to adopt it will be left behind. Make this your personal strategic imperative. Make AI your teammate to augment your daily work routine. The time to start is now – because an AI-powered future is closer than it appears!